Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the Americas, Europe, the Middle East, Africa, Asia, and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis,…
| Price | $8.01 |
|---|---|
| Market cap | $36.13M |
| Sector | Healthcare |
| Industry | Medical - Instruments & Supplies |
| Exchange | NASDAQ |
| 52-week range | 3.8-9.4 |
| Beta | 1.53 |
Explore HBIO's full valuation scorecard, price history, financial statements, insider and institutional ownership, and peer comparison on this page — free, no login required.